LOS ANGELES CAPITAL MANAGEMENT LLC - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 219 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.

Quarter-by-quarter ownership
LOS ANGELES CAPITAL MANAGEMENT LLC ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q4 2021$435,000
-32.2%
5,169
-27.4%
0.00%
-33.3%
Q3 2021$642,000
-5.4%
7,1180.0%0.00%0.0%
Q2 2021$679,000
-40.4%
7,118
-28.8%
0.00%
-40.0%
Q1 2021$1,139,000
-56.2%
10,004
-46.7%
0.01%
-54.5%
Q4 2020$2,600,000
+69.4%
18,781
+0.5%
0.01%
+57.1%
Q3 2020$1,535,000
+28.1%
18,680
+21.9%
0.01%
+16.7%
Q2 2020$1,198,000
+106.6%
15,320
+17.3%
0.01%
+50.0%
Q1 2020$580,000
+134.8%
13,060
+126.0%
0.00%
+300.0%
Q3 2019$247,000
-32.7%
5,7800.0%0.00%
-50.0%
Q2 2019$367,000
-67.6%
5,780
-64.6%
0.00%
-66.7%
Q1 2019$1,132,000
+50.3%
16,320
-5.8%
0.01%
+20.0%
Q4 2018$753,000
-37.6%
17,320
+9.6%
0.01%
-16.7%
Q3 2018$1,207,000
+9.3%
15,805
+10.0%
0.01%0.0%
Q2 2018$1,104,000
+46.8%
14,365
-2.6%
0.01%
+50.0%
Q1 2018$752,00014,7450.00%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q3 2023
NameSharesValueWeighting ↓
First Light Asset Management, LLC 213,887$29,608,0002.19%
Rock Springs Capital Management LP 566,500$78,421,0001.66%
FEDERATED HERMES, INC. 4,280,528$592,554,0001.21%
AtonRa Partners 17,646$2,443,0001.20%
EMERALD MUTUAL FUND ADVISERS TRUST 218,390$30,232,0001.05%
EMERALD ADVISERS, LLC 226,875$31,406,0001.04%
Atika Capital Management LLC 89,000$12,319,0000.96%
Capital Impact Advisors, LLC 25,582$3,541,0000.87%
JGP Global Gestao de Recursos Ltda. 1,586$220,0000.83%
CAPITAL INTERNATIONAL LTD /CA/ 79,742$11,039,0000.64%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders